Is the Wegovy pill available in Canada?

Not as of October 2026. The FDA approved oral Wegovy in the US in December 2025 and Novo Nordisk has applied in Canada, but Health Canada has not authorized it. Rybelsus is the only authorized oral semaglutide in Canada, for type 2 diabetes.

Is Foundayo (orforglipron) approved in Canada?

Not as of October 2026. It was FDA-approved in the US in 2026; in Canada it has no Notice of Compliance yet, and Canada's Drug Agency began a reimbursement review in June 2026.

Which GLP-1 drugs are approved in Canada?

Health Canada has authorized semaglutide (Ozempic, Wegovy, Rybelsus and 2026 generics), tirzepatide (Mounjaro, Zepbound; a GIP/GLP-1 agonist) and liraglutide (Victoza, Saxenda), among others. All are prescription-only.

Is there a generic GLP-1 in Canada?

Yes. Canada authorized the first generic semaglutide in April 2026 and a generic for weight management (Sevmia) in June 2026. Generic liraglutide submissions are still listed as under review by Health Canada.

Are GLP-1 drugs covered in Canada?

It depends on your plan. Public plans such as the Ontario Drug Benefit list Ozempic for type 2 diabetes under criteria; weight-management GLP-1s are generally not on public formularies. Private plans vary.

Are 'research' GLP-1 peptides legal in Canada?

No. Health Canada says unauthorized peptides cannot be sold for human use and 'research use only' labels give no exemption.

Does this page recommend a clinic, product or dose?

No. We don't list clinics, sellers, prices or doses, and nothing here is medical advice. Talk to a licensed prescriber or pharmacist.

Canada \u00b7 GLP-1

GLP-1 medications in Canada: what's authorized and what users report.

“GLP-1” is the class of medicines behind Ozempic, Wegovy, Mounjaro and Zepbound. In Canada every one of them is a prescription drug that must be authorized by Health Canada. This page lists what is authorized, what isn't, and what anonymous users on Peptide Confessions report. We don't sell anything.

Authorized GLP-1 medicines in Canada

Semaglutide — Ozempic (type 2 diabetes), Wegovy (weight management), Rybelsus (oral tablet) and the first generic semaglutide (2026 generics).
Tirzepatide — Mounjaro (type 2 diabetes) and Zepbound (weight management).
Liraglutide — Victoza (type 2 diabetes) and Saxenda (weight management); see liraglutide in Canada.

Check any product's DIN in the Drug Product Database.

Canadian GLP-1 drugs compared

Last reviewed October 15, 2026against Health Canada's Drug Product Database.

Brand	Molecule	Maker	Canadian indication	Form	Generic in Canada?
Ozempic	Semaglutide	Novo Nordisk	Type 2 diabetes	Weekly injection	Yes, since 2026
Wegovy	Semaglutide	Novo Nordisk	Weight management	Weekly injection	Same molecule; see generics page
Rybelsus	Semaglutide	Novo Nordisk	Type 2 diabetes	Daily tablet	No
Mounjaro	Tirzepatide (GIP + GLP-1)	Eli Lilly	Type 2 diabetes	Weekly injection	No
Zepbound	Tirzepatide (GIP + GLP-1)	Eli Lilly	Weight management	Weekly injection	No
Victoza	Liraglutide	Novo Nordisk	Type 2 diabetes	Daily injection	In review
Saxenda	Liraglutide	Novo Nordisk	Weight management	Daily injection	In review
Trulicity	Dulaglutide	Eli Lilly	Type 2 diabetes	Weekly injection	No

Not in the Drug Product Database as of this review: retatrutide, orforglipron (Foundayo) and the Wegovy pill.

Not authorized

Retatrutide and other investigational GLP-1 agonists — still in clinical trials.
“Research” or compounded GLP-1 vials sold online — Health Canada's April 2026 advisory warns these can seriously harm. More: compounded GLP-1 in Canada.

Coverage, briefly

Coverage depends on province and plan. See Is Ozempic covered in Canada? for how public and private plans treat GLP-1s.

What semaglutide users report

37 published anonymous semaglutide confessions; 5 mention at least one side effect.
12 mention Ozempic, Wegovy or Rybelsus by name.
Among confessions that state a weight change in pounds, the median reported is 50 lb. Self-reported, unverified.

Most-mentioned side effects (share of semaglutide confessions):

Burping: 5.4% (2)
Nausea: 5.4% (2)
Vomiting: 5.4% (2)
Anxiety or panic: 2.7% (1)
Constipation: 2.7% (1)

Counts are phrase mentions in anonymous accounts, not diagnoses or clinical rates. Full breakdown and methodology: semaglutide side-effects report.

What tirzepatide users report

93 published anonymous tirzepatide confessions; 27 mention at least one side effect.
10 mention Mounjaro or Zepbound by name.
Among confessions that state a weight change in pounds, the median reported is 50 lb. Self-reported, unverified.

Most-mentioned side effects (share of tirzepatide confessions):

Heart rate or palpitations: 11.8% (11)
Anxiety or panic: 5.4% (5)
Burping: 4.3% (4)
Insomnia or poor sleep: 3.2% (3)
Libido: 3.2% (3)

Counts are phrase mentions in anonymous accounts, not diagnoses or clinical rates. Full breakdown and methodology: tirzepatide side-effects report.

Side effects

What Canadian writers tell us

Very few published confessions name a Canadian city or province, so we do not report Canada-only statistics. As of October 15, 2026, the handful that do are about retatrutide, an unapproved investigational drug, not about Ozempic, Wegovy, Mounjaro or Zepbound. Three themes come up:

Large self-reported weight loss over several months, sometimes alongside other unapproved peptides.
Frustration with cost, which pushes some people toward unregulated online sellers.
Little understanding of what they are taking (“I don't even understand how it works”).

That last point is the risk Health Canada flags in its April 2026 advisory on peptides bought online. We don't name sellers, prices or doses. If you're in Canada and have used an authorized GLP-1, sharing your experience anonymously from the homepage helps make these pages more useful.

By province and city

Frequently asked questions

Is the Wegovy pill available in Canada?: Not as of October 2026. The FDA approved oral Wegovy in the US in December 2025 and Novo Nordisk has applied in Canada, but Health Canada has not authorized it. Rybelsus is the only authorized oral semaglutide in Canada, for type 2 diabetes.
Is Foundayo (orforglipron) approved in Canada?: Not as of October 2026. It was FDA-approved in the US in 2026; in Canada it has no Notice of Compliance yet, and Canada's Drug Agency began a reimbursement review in June 2026.
Which GLP-1 drugs are approved in Canada?: Health Canada has authorized semaglutide (Ozempic, Wegovy, Rybelsus and 2026 generics), tirzepatide (Mounjaro, Zepbound; a GIP/GLP-1 agonist) and liraglutide (Victoza, Saxenda), among others. All are prescription-only.
Is there a generic GLP-1 in Canada?: Yes. Canada authorized the first generic semaglutide in April 2026 and a generic for weight management (Sevmia) in June 2026. Generic liraglutide submissions are still listed as under review by Health Canada.
Are GLP-1 drugs covered in Canada?: It depends on your plan. Public plans such as the Ontario Drug Benefit list Ozempic for type 2 diabetes under criteria; weight-management GLP-1s are generally not on public formularies. Private plans vary.
Are 'research' GLP-1 peptides legal in Canada?: No. Health Canada says unauthorized peptides cannot be sold for human use and 'research use only' labels give no exemption.
Does this page recommend a clinic, product or dose?: No. We don't list clinics, sellers, prices or doses, and nothing here is medical advice. Talk to a licensed prescriber or pharmacist.

Sources

General information only — not medical, legal or regulatory advice. Peptide Confessions does not sell, source or recommend any product or vendor, and nothing here is dosing guidance. Speak with a licensed Canadian healthcare professional or pharmacist about any medication. Editorial process →